Canadian Generics Campaign In Quebec

27 January 1997

The Canadian Drug Manufacturers' Association, representing the genericsindustry, has launched a radio advertising campaign in Quebec, encouraging consumers to ask their physicians and pharmacists about generic alternatives to their branded drugs.

The campaign has been designed to coincide with the introduction of Quebec's new mandatory drug insurance program on January 1. The program now covers anyone who was not previously enrolled in a government or private plan, but also requires many people who had previously received their drugs free of charge to start contributing to their drugs' costs.

The CDMA notes that at 8.5%, generics account for a small share of Quebec's annual C$1.52 billion ($1.14 billion) drugs budget, compared with 18.8% in British Columbia, 18.4% in Atlantic Canada and 15% in Ontario. This low level, it says, is due to the fact that while every other Canadian provincial drug plan pays for only the cheapest available product, Quebec's health insurance agency, the Regie de l'Assurance-Maladie du Quebec, continues paying for branded drugs until they are 15 years old, and continues to pay for older drugs until at least three competitor products arrive on the market.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight